Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 163

1.

G Protein-coupled Estrogen Receptor Protects from Atherosclerosis.

Meyer MR, Fredette NC, Howard TA, Hu C, Ramesh C, Daniel C, Amann K, Arterburn JB, Barton M, Prossnitz ER.

Sci Rep. 2014 Dec 23;4:7564. doi: 10.1038/srep07564.

PMID:
25532911
[PubMed - in process]
Free PMC Article
2.

Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MSn techniques.

Welter J, Kavanagh P, Meyer MR, Maurer HH.

Anal Bioanal Chem. 2014 Dec 4. [Epub ahead of print]

PMID:
25471293
[PubMed - as supplied by publisher]
3.

Witnessed drug intake before planned denervation-Always harmless?

Linicus Y, Kindermann I, Helfer AG, Meyer MR, Maurer HH, Mahfoud F, Böhm M.

Int J Cardiol. 2015 Jan 20;179:125-6. doi: 10.1016/j.ijcard.2014.10.162. Epub 2014 Oct 28. No abstract available.

PMID:
25464430
[PubMed - in process]
4.

Contribution of human esterases to the metabolism of selected drugs of abuse.

Meyer MR, Schütz A, Maurer HH.

Toxicol Lett. 2014 Oct 24;232(1):159-166. doi: 10.1016/j.toxlet.2014.10.026. [Epub ahead of print]

PMID:
25445008
[PubMed - as supplied by publisher]
5.

Prospective risk of fetal death with gastroschisis.

Meyer MR, Shaffer BL, Doss AE, Cahill AG, Snowden JM, Caughey AB.

J Matern Fetal Neonatal Med. 2014 Dec 23:1-4. [Epub ahead of print]

PMID:
25428833
[PubMed - as supplied by publisher]
6.

In vitro cytochrome P450 inhibition potential of methylenedioxy-derived designer drugs studied with a two-cocktail approach.

Dinger J, Meyer MR, Maurer HH.

Arch Toxicol. 2014 Nov 23. [Epub ahead of print]

PMID:
25417051
[PubMed - as supplied by publisher]
7.

Current position of high-resolution MS for drug quantification in clinical & forensic toxicology.

Meyer MR, Helfer AG, Maurer HH.

Bioanalysis. 2014 Aug;6(17):2275-84. doi: 10.4155/bio.14.164.

PMID:
25383737
[PubMed - in process]
8.

Forensic and clinical toxicology.

Meyer MR, Maurer HH.

Bioanalysis. 2014 Aug;6(17):2187. doi: 10.4155/bio.14.193. No abstract available.

PMID:
25383730
[PubMed - in process]
Free Article
9.

Instrumentation for the detection and characterization of exoplanets.

Pepe F, Ehrenreich D, Meyer MR.

Nature. 2014 Sep 18;513(7518):358-66. doi: 10.1038/nature13784.

PMID:
25230658
[PubMed]
10.

Preference toward future mode of delivery: how do antepartum preferences and prior delivery experience contribute?

Sparks TN, Yeaton-Massey A, Granados JM, Handler SJ, Meyer MR, Caughey AB.

J Matern Fetal Neonatal Med. 2014 Oct 6:1-6. [Epub ahead of print]

PMID:
25212977
[PubMed - as supplied by publisher]
11.

Trends in analyzing emerging drugs of abuse--from seized samples to body samples.

Meyer MR.

Anal Bioanal Chem. 2014 Oct;406(25):6105-10. doi: 10.1007/s00216-014-8082-3. Epub 2014 Aug 17.

PMID:
25129635
[PubMed - in process]
12.

Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS (n) , and LC-high-resolution-MS (n.).

Wink CS, Meyer MR, Braun T, Turcant A, Maurer HH.

Anal Bioanal Chem. 2015 Jan;407(3):831-43. doi: 10.1007/s00216-014-8083-2. Epub 2014 Aug 14.

PMID:
25120185
[PubMed - in process]
13.

Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse.

Dinger J, Meyer MR, Maurer HH.

Toxicol Lett. 2014 Oct 1;230(1):28-35. doi: 10.1016/j.toxlet.2014.08.004. Epub 2014 Aug 8.

PMID:
25111188
[PubMed - indexed for MEDLINE]
14.

Studies on the microbial biotransformation of the novel psychoactive substance methylenedioxypyrovalerone (MDPV) in wastewater by means of liquid chromatography-high resolution mass spectrometry/mass spectrometry.

Mardal M, Meyer MR.

Sci Total Environ. 2014 Sep 15;493:588-95. doi: 10.1016/j.scitotenv.2014.06.016. Epub 2014 Jun 28.

PMID:
24982024
[PubMed - in process]
15.

CPTAC Assay Portal: a repository of targeted proteomic assays.

Whiteaker JR, Halusa GN, Hoofnagle AN, Sharma V, MacLean B, Yan P, Wrobel JA, Kennedy J, Mani DR, Zimmerman LJ, Meyer MR, Mesri M, Rodriguez H; Clinical Proteomic Tumor Analysis Consortium (CPTAC), Paulovich AG.

Nat Methods. 2014 Jul;11(7):703-4. doi: 10.1038/nmeth.3002. No abstract available.

PMID:
24972168
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MSn standard screening approaches.

Helfer AG, Turcant A, Boels D, Ferec S, Lelièvre B, Welter J, Meyer MR, Maurer HH.

Drug Test Anal. 2014 Jun 22. doi: 10.1002/dta.1682. [Epub ahead of print]

PMID:
24953431
[PubMed - as supplied by publisher]
17.

Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktail.

Dinger J, Meyer MR, Maurer HH.

Anal Bioanal Chem. 2014 Jul;406(18):4453-64. doi: 10.1007/s00216-014-7849-x. Epub 2014 May 16.

PMID:
24830396
[PubMed - in process]
18.

Racial/ethnic variations in perineal length and association with perineal lacerations: a prospective cohort study.

Yeaton-Massey A, Wong L, Sparks TN, Handler SJ, Meyer MR, Granados JM, Stasenko M, Sit A, Caughey AB.

J Matern Fetal Neonatal Med. 2014 May 22:1-4. [Epub ahead of print]

PMID:
24749802
[PubMed - as supplied by publisher]
19.
20.

Toxicokinetics of novel psychoactive substances: characterization of N-acetyltransferase (NAT) isoenzymes involved in the phase II metabolism of 2C designer drugs.

Meyer MR, Robert A, Maurer HH.

Toxicol Lett. 2014 Jun 5;227(2):124-8. doi: 10.1016/j.toxlet.2014.03.010. Epub 2014 Mar 25.

PMID:
24674864
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk